Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alina Wilkowska, Adam Włodarczyk, Maria Gałuszko-Węgielnik, Mariusz S Wiglusz & Wiesław J Cubała. (2021) Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study. Neuropsychiatric Disease and Treatment 17, pages 2637-2646.
Read now
Read now
Alina Wilkowska, Łukasz Szałach & Wiesław J Cubała. (2020) Ketamine in Bipolar Disorder: A Review. Neuropsychiatric Disease and Treatment 16, pages 2707-2717.
Read now
Read now
Joanna Szarmach, Wiesław Jerzy Cubała, Adam Włodarczyk & Maria Gałuszko-Węgielnik. (2020) Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression. Neuropsychiatric Disease and Treatment 16, pages 2539-2551.
Read now
Read now
Joanna Kryst, Paweł Kawalec & Andrzej Pilc. (2020) Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder. Expert Opinion on Pharmacotherapy 21:1, pages 9-20.
Read now
Read now
Kai Zhang & Kenji Hashimoto. (2019) An update on ketamine and its two enantiomers as rapid-acting antidepressants. Expert Review of Neurotherapeutics 19:1, pages 83-92.
Read now
Read now
Articles from other publishers (19)
Hannah Hartland, Kimia Mahdavi, Luke A Jelen, Rebecca Strawbridge, Allan H Young & Laith Alexander. (2023) A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects. Journal of Psychopharmacology, pages 026988112311616.
Crossref
Crossref
Adam Włodarczyk, Alicja Dywel & Wiesław Jerzy Cubała. (2023) Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms. Pharmaceuticals 16:2, pages 173.
Crossref
Crossref
Yazen Alnefeesi, David Chen-Li, Ella Krane, Muhammad Youshay Jawad, Nelson B. Rodrigues, Felicia Ceban, Joshua D. Di Vincenzo, Shakila Meshkat, Roger C.M. Ho, Hartej Gill, Kayla M. Teopiz, Bing Cao, Yena Lee, Roger S. McIntyre & Joshua D. Rosenblat. (2022) Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis. Journal of Psychiatric Research 151, pages 693-709.
Crossref
Crossref
Sanne Y Smith-Apeldoorn, Maurice Vischjager, Jolien KE Veraart, Jeanine Kamphuis, Marije aan het Rot & Robert A Schoevers. (2022) The antidepressant effect and safety of non-intranasal esketamine: A systematic review. Journal of Psychopharmacology 36:5, pages 531-544.
Crossref
Crossref
诗立 孙. (2022) New Progress in the Treatment of Refractory Depression with Esticketamine. Advances in Clinical Medicine 12:05, pages 4090-4095.
Crossref
Crossref
Amanda Decker, Brandon Bacalzo & Mark J. Niciu. 2022. Biomarkers in Bipolar Disorders. Biomarkers in Bipolar Disorders
215
252
.
Maria Gałuszko-Wȩgielnik, Adam Włodarczyk, Wiesław Jerzy Cubała, Alina Wilkowska, Natalia Górska & Jakub Słupski. (2021) Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases. Frontiers in Psychiatry 12.
Crossref
Crossref
John Martin Corkery, Wan-Chu Hung, Hugh Claridge, Christine Goodair, Caroline S Copeland & Fabrizio Schifano. (2021) Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019. Journal of Psychopharmacology 35:11, pages 1324-1348.
Crossref
Crossref
Rodrigo P. Mello, Mariana V.F. Echegaray, Ana Paula Jesus-Nunes, Gustavo C. Leal, Guilherme M. Magnavita, Flávia Vieira, Ana Teresa Caliman-Fontes, Manuela Telles, Lívia N.F. Guerreiro-Costa, Breno Souza-Marques, Igor D. Bandeira, Cassio Santos-Lima, Roberta F. Marback, Fernanda S. Correia-Melo, Acioly L.T. Lacerda & Lucas C. Quarantini. (2021) Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial. Journal of Psychiatric Research 138, pages 576-583.
Crossref
Crossref
Gustavo C. Leal, Igor D. Bandeira, Fernanda S. Correia-Melo, Manuela Telles, Rodrigo P. Mello, Flavia Vieira, Cassio S. Lima, Ana Paula Jesus-Nunes, Lívia N. F. Guerreiro-Costa, Roberta F. Marback, Ana Teresa Caliman-Fontes, Breno L. S. Marques, Marília L. O. Bezerra, Alberto L. Dias-Neto, Samantha S. Silva, Aline S. Sampaio, Gerard Sanacora, Gustavo Turecki, Colleen Loo, Acioly L. T. Lacerda & Lucas C. Quarantini. (2020) Intravenous arketamine for treatment-resistant depression: open-label pilot study. European Archives of Psychiatry and Clinical Neuroscience 271:3, pages 577-582.
Crossref
Crossref
Adam Włodarczyk, Wiesław J. Cubała, Maria Gałuszko-Węgielnik & Joanna Szarmach. (2021) Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression. Therapeutic Advances in Psychopharmacology 11, pages 204512532110110.
Crossref
Crossref
Lei Zou, Su Min, Qibin Chen, Xiao Li & Li Ren. (2020) Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients—A randomized, double‐blind, controlled clinical study. Brain and Behavior 11:1.
Crossref
Crossref
Domenico De Berardis, Carmine Tomasetti, Maurizio Pompili, Gianluca Serafini, Federica Vellante, Michele Fornaro, Alessandro Valchera, Giampaolo Perna, Umberto Volpe, Giovanni Martinotti, Silvia Fraticelli, Massimo Di Giannantonio, Yong-Ku Kim & Laura Orsolini. (2020) An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine. Current Topics in Medicinal Chemistry 20:7, pages 554-584.
Crossref
Crossref
Fernanda S. Correia-Melo, Gustavo C. Leal, Flávia Vieira, Ana Paula Jesus-Nunes, Rodrigo P. Mello, Guilherme Magnavita, Ana Teresa Caliman-Fontes, Mariana V.F. Echegaray, Igor D. Bandeira, Samantha S. Silva, Diogo E. Cavalcanti, Lucas Araújo-de-Freitas, Luciana M. Sarin, Marco A. Tuena, Carolina Nakahira, Aline S. Sampaio, José A. Del-Porto, Gustavo Turecki, Colleen Loo, Acioly L.T. Lacerda & Lucas C. Quarantini. (2020) Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study. Journal of Affective Disorders 264, pages 527-534.
Crossref
Crossref
Adam Włodarczyk & Wiesław Jerzy Cubała. (2020) Safety and Tolerability of Ketamine Use in Treatment-Resistant Bipolar Depression Patients with Regard to Central Nervous System Symptomatology: Literature Review and Analysis. Medicina 56:2, pages 67.
Crossref
Crossref
Jun Dong, Su Min, Haitang Qiu, Qibing Chen & Li Ren. (2019) Intermittent administration of low dose ketamine can shorten the course of electroconvulsive therapy for depression and reduce complications: A randomized controlled trial. Psychiatry Research 281, pages 112573.
Crossref
Crossref
Fernanda S. Correia-Melo, Gustavo C. Leal, Michelle S. Carvalho, Ana Paula Jesus-Nunes, Carolina B.N. Ferreira, Flávia Vieira, Guilherme Magnavita, Lucas A.S. Vale, Rodrigo P. Mello, Carolina Nakahira, Felipe C. Argolo, Tanise Cardoso, Cezar D.S. Souza, Ana Teresa C. Fontes, Marcelo B. Ferreira, Lucas Araújo-de-Freitas, Marco A. Tuena, Mariana V.F. Echegaray, Diogo E. Cavalcanti, Ana C. Lucchese, Igor D. Bandeira, Manuela Telles, Cássio S. Lima, Aline S. Sampaio, Samantha S. Silva, Roberta F. Marback, José A. Del-Porto, José Neander Abreu, Luciana M. Sarin, Camilla S. Paixão, Lucas P. Carvalho, Paulo R.L. Machado, Gustavo Turecki, Acioly L.T. Lacerda & Lucas C. Quarantini. (2018) Comparative study of esketamine and racemic ketamine in treatment-resistant depression. Medicine 97:38, pages e12414.
Crossref
Crossref
P. Molero, J. A. Ramos-Quiroga, R. Martin-Santos, E. Calvo-Sánchez, L. Gutiérrez-Rojas & J. J. Meana. (2018) Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review. CNS Drugs 32:5, pages 411-420.
Crossref
Crossref
Michael E. Thase. (2018) New medications for treatment-resistant depression: a brief review of recent developments. CNS Spectrums 22:S1, pages 39-48.
Crossref
Crossref